D-1014-2020 Class II Terminated
FDA drug recall D-1014-2020 was initiated by Perrigo Company PLC on Oct 23, 2019 and is designated Class II. Reason for recall: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. The recall status is terminated (terminated Nov 6, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2020
- Initiation Date
- Oct 23, 2019
- Termination Date
- Nov 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets per bottle. [NDC: Brand] NDC Basic Care: 0113-7876-27; NDC CVS Health: 69842-293-27; NDC Leader: 70000-0375-2; NDC Up & Up: 11673-876-27; NDC Walgreens: 0363-1876-27
Reason for recall
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Distribution pattern
Nationwide USA
Code information
Lots: 8CE1643, 8DE1370, 8DE1768, 8EE1560, 8FE1452, 8GE1341, 8HE1223, 8KE2832, 8KE2246, 8ME2725, 9AE2835, 9CE3378, 9DE2748, 9EE2637, 9FE2976, 9GE2795, 9GE3228, 9HE3617
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1014-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026